SCHEMBL6933641

SCHEMBL6933641

CCCc1c(O)ccc(C(=O)CCc2ccccc2)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.56
CYP1B1 Q16678 1/20 0.56
LMNA P02545 3/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.50
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP19A1 P11511 1/20 0.47
GAA P10253 1/20 0.47
SLC5A1 P13866 1/20 0.47
SLC5A2 P31639 1/20 0.47
ALDH1A1 P00352 1/20 0.44
ABCB1 P08183 7/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KEAP1 Q14145 1/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7041414 0.87 LMNA (0.65) CYP1A1CYP1B1LMNAMAPTHPGD
SCHEMBL7044950 0.85 HPGD (0.49) CYP1A1CYP1B1LMNAMAPTHPGD
SCHEMBL30736448 0.82 CYP1A1 (0.65) CYP1A1CYP1B1LMNAMAPTHPGD
SCHEMBL4017548 0.80 HSP90AB1 (0.49) LMNAMAPTHPGDMEN1HTT
SCHEMBL7968004 0.79 HTT (0.55) MAPTMEN1HTTKMT2AALDH1A1
SCHEMBL10726758 0.78 SELL (0.53) LMNAMAPTHPGDALDH1A1CYP1A2
SCHEMBL9579685 0.78 TDP1 (0.56) LMNAMAPTHPGDMEN1HTT
SCHEMBL2862125 0.78 MAPT (0.49) LMNAMAPTHPGDMEN1HTT
SCHEMBL29215531 0.78 CYP1A1 (0.60) CYP1A1CYP1B1MAPTMEN1KMT2A
SCHEMBL19401241 0.78 CYP1A1 (0.60) CYP1A1CYP1B1LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888278-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2003-07-23 EP disclosed
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0888278-A4 ANTIDIABETIC AGENTS MERCK & CO INC (US) 1999-06-30 EP disclosed
EP-0888278-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-01-07 EP disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed
WO-1997028115-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed